Publications by authors named "Eyrydiki Michalis"
Central nervous system (CNS) involvement is a rare and aggressive complication of multiple myeloma (MM). We identified 54/4352 MM patients (1.2%), who developed CNS-MM between 2000 and 2022.
View Article and Find Full Text PDFArticle Synopsis
- Researchers studied how effective new treatments called VRd and DBQ are for patients with a type of blood cancer called primary plasma cell leukemia (pPCL) compared to older treatments.
- They looked at 110 patients and found that those treated with the new treatments had better results, with nearly 83% of them responding well to the treatment.
- Overall, patients using VRd/DBQ lived longer and had fewer complications than those on older treatments, making it the best option for treating pPCL right now.